Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
Revision as of 13:56, 3 November 2023 by Bailey.Glen (talk | contribs)
editPREVIOUS EDITIONThis page from the 4th edition of Haematolymphoid Tumours is being updated. See 5th edition Table of Contents.
Primary Author(s)*
Derick Okwan MD, PhD (Stanford Medicine, CA)
Sumire Kitahara MD (Cedars-Sinai, CA)
Cancer Category/Type
Mature T- and NK-cell Neoplasms
Cancer Sub-Classification / Subtype
Definition / Description of Disease
- Category that is assigned T-cell lymphoma entities that do not meet diagnostic criteria for Enteropathy-Associated T-cell Lymphoma or Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
- Typically assigned in the setting of inadequate biopsy, equivocal assessment of mucosal surface, incomplete immunophenotype, or incomplete clinical history where celiac disease is uninvolved
- Not a distinct clinical entity
Synonyms / Terminology
- N/A
Epidemiology / Prevalence
- N/A
Clinical Features
- Aggressive disease with typically widespread involvement[1]
- Not associated with celiac disease[1]
- Weight loss, anorexia, fatigue, possible intestinal obstruction/perforation[1]
- May not respond to standard therapy indicated for enteropathy-associated T-cell lymphoma or monomorphic epitheliotropic intestinal T-cell lymphoma[1]
Sites of Involvement
- Intestinal tract (predominantly colon)
Morphologic Features
- Heterogeneous, variable-sized lymphocytic infiltrate
- Shares features compatible with both enteropathy-associated T-cell lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma
Immunophenotype
- N/A
Chromosomal Rearrangements (Gene Fusions)
- No unique disease-specific genetic features
Characteristic Chromosomal Aberrations / Patterns
- No unique disease-specific chromosomal pattern
Genomic Gain/Loss/LOH
- N/A
Gene Mutations (SNV/INDEL)
- N/A
Other Mutations
- N/A
Epigenomics (Methylation)
- Not described
Genes and Main Pathways Involved
- N/A
Diagnostic Testing Methods
- Must rule out definitive diagnosis of enteropathy-associated T-cell lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma
Clinical Significance (Diagnosis, Prognosis and Therapeutic Implications)
- Aggressive course
- Must rule out all definitive diagnoses, including enteropathy-associated T-cell lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma and indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
Familial Forms
- None
Other Information
Links
References
- ↑ 1.0 1.1 1.2 1.3 Attygalle, Ayoma D; et al. (2014). "Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology". Histopathology. 64 (2): 171–199. doi:10.1111/his.12251. ISSN 0309-0167. PMC 6364972. PMID 24128129.
Notes
*Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.